CD40 and neoplasm: Studies on novel methods of treatment have been conducted on murine models, using anti-CD40 and anti-CD40L antibodies, recombinant CD40L, and transformed viral vectors, carrying encoding sequences/ligand genes or vaccines, to the production of which dendritic cells containing tumor peptides and CD40L gene are used [86, 87].